Industry, policymakers focus on AI-led regulatory harmonisation, FTAs, MSME support and market expansion as exports touch $28.29 billion till February FY26
India’s pharmaceutical sector stands at a pivotal inflection point
India’s traditional medicine systems have also earned formal recognition in key bilateral trade agreements
Enhance strategies to drive sustainability, global Reach and digital transformation for a trillion-dollar future
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
Candle Partners, an investment banking & advisory service for M&A among others, has closed many deals in the healthcare space. Ankit Poddar, Director, Candle Partners spoke to Thomas C Thottathil, Editor, Indianpharmapost.com about the prospects for the industry.
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.
Drugs and pharmaceuticals were among the top eight export items in H1FY22, according to a Care Ratings report.
_256_384.jpg)
In the period April to August 2021, exports stood at Rs 73,469.29 crores compared to Rs 72,275.22 crores for the period April to August 2020 a growth of 1.65 per cent
Subscribe To Our Newsletter & Stay Updated
